Mr. Richard Carleton reports

CSE CONFIRMS POSITION ON U.S. CANNABIS LISTINGS

Canadian Securities Exchange has released guidance pertaining to listings of cannabis companies with assets or operations in the United States. There is significant uncertainty in Canada surrounding these listings, and the CSE wishes to confirm its position.

Risk disclosure

Currently, there are conflicting U.S. federal and state laws concerning the legality of medical and recreational cannabis. The CSE maintains that companies with exposure to the U.S. cannabis industry need to provide a complete risk disclosure for investors. This should include a comprehensive discussion of the current legal framework. All CSE-listed companies are required to comply.

Public interest

The exchange has an obligation and a commitment to consider the public interest during the listing process. Accordingly, the exchange will continue to accept applications from companies that meet listing requirements and provide appropriate disclosure. "The CSE is the exchange for entrepreneurs, and we are pleased to be receiving growing interest from entrepreneurs in the U.S. cannabis space, where a rapidly evolving legal framework has created significant investment opportunities," said Richard Carleton, chief executive officer. "Provided that these companies offer appropriate risk disclosure and demonstrate that they are operating in accordance with applicable laws, we believe that they are valuable additions to our well-regulated exchange."

For more information, including a list of frequently asked questions pertaining to listings of cannabis companies with exposure to the United States, please view the CSE's guidance document on its website.

About Canadian Securities Exchange

The CSE is home to more than 300 uniquely listed issues covering a broad range of industry sectors. The exchange provides trade execution, smart routing, risk management, compliance and market information services for Canadian-listed instruments.